Armistice Capital’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,000,000
| Closed | -$19.6M | – | 187 |
|
|
2021
Q3 | $19.6M | Buy |
4,000,000
+144,000
| +4% | +$707K | 0.33% | 70 |
|
|
2021
Q2 | $20.4M | Hold |
3,856,000
| – | – | 0.36% | 65 |
|
|
2021
Q1 | $18.5M | Buy |
3,856,000
+1,114,000
| +41% | +$5.35M | 0.43% | 57 |
|
|
2020
Q4 | $11.9M | Hold |
2,742,000
| – | – | 0.4% | 61 |
|
|
2020
Q3 | $11.3M | Hold |
2,742,000
| – | – | 0.41% | 57 |
|
|
2020
Q2 | $7.02M | Hold |
2,742,000
| – | – | 0.31% | 64 |
|
|
2020
Q1 | $7.92M | Buy |
2,742,000
+546,000
| +25% | +$1.58M | 0.49% | 55 |
|
|
2019
Q4 | $8.32M | Buy |
2,196,000
+1,660,000
| +310% | +$6.29M | 0.48% | 49 |
|
|
2019
Q3 | $2.74M | Sell |
536,000
-2,164,000
| -80% | -$11.1M | 0.18% | 51 |
|
|
2019
Q2 | $16.7M | Sell |
2,700,000
-44,000
| -2% | -$273K | 1.06% | 27 |
|
|
2019
Q1 | $19.5M | Buy |
2,744,000
+2,086,000
| +317% | +$14.8M | 1.07% | 24 |
|
|
2018
Q4 | $5.62M | Buy |
+658,000
| New | +$5.62M | 0.43% | 44 |
|
|
2017
Q4 | – | Sell |
-750,000
| Closed | -$15.9M | – | 81 |
|
|
2017
Q3 | $15.9M | Sell |
750,000
-408,000
| -35% | -$8.64M | 1.87% | 12 |
|
|
2017
Q2 | $20.3M | Buy |
1,158,000
+294,000
| +34% | +$5.14M | 2.58% | 7 |
|
|
2017
Q1 | $15.1M | Buy |
864,000
+328,000
| +61% | +$5.74M | 3.12% | 7 |
|
|
2016
Q4 | $9.06M | Buy |
+536,000
| New | +$9.06M | 2.14% | 17 |
|